Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Gaurav Singh, Stanislav N Tolkachjov & Aaron S Farberg. (2023) Incorporation of the 40-Gene Expression Profile (40-GEP) Test to Improve Treatment Decisions in High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients: Case Series and Algorithm. Clinical, Cosmetic and Investigational Dermatology 16, pages 925-935.
Read now
Read now
Perry B. Hooper, Aaron S. Farberg, Alison L. Fitzgerald, Jennifer J. Siegel, Briana B. Rackley, Anesh Prasai, Sarah J. Kurley, Matthew S. Goldberg & Graham H. Litchman. (2022) Real-World Evidence Shows Clinicians Appropriately Use the Prognostic 40-Gene Expression Profile (40-GEP) Test for High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients. Cancer Investigation 40:10, pages 911-922.
Read now
Read now
Sherrif F Ibrahim, Julia M Kasprzak, Mary A Hall, Alison L Fitzgerald, Jennifer J Siegel, Sarah J Kurley, Kyle R Covington, Matthew S Goldberg, Aaron S Farberg, Shannon C Trotter, Kenneth Reed, David G Brodland, Shlomo A Koyfman, Ally-Khan Somani, Sarah T Arron & Ashley Wysong. (2022) Enhanced Metastatic Risk Assessment in Cutaneous Squamous Cell Carcinoma with the 40-Gene Expression Profile Test. Future Oncology 18:7, pages 833-847.
Read now
Read now
Graham H. Litchman, Alison L. Fitzgerald, Sarah J. Kurley, Robert W. Cook & Darrell S. Rigel. (2020) Impact of a prognostic 40-gene expression profiling test on clinical management decisions for high-risk cutaneous squamous cell carcinoma. Current Medical Research and Opinion 36:8, pages 1295-1300.
Read now
Read now
Articles from other publishers (13)
Brent R. Moody, Aaron S. Farberg, Ally-Khan Somani & Walton A. Taylor. (2024) Inconsistent Associations Between Risk Factor Profiles and Adjuvant Radiation Therapy (ART) Treatment in Patients with Cutaneous Squamous Cell Carcinoma and Utility of the 40-Gene Expression Profile to Refine ART Guidance. Dermatology and Therapy 14:4, pages 861-873.
Crossref
Crossref
Ashley Wysong, Ally‐Khan Somani, Sherrif F. Ibrahim, Javier Cañueto, Alison L. Fitzgerald, Jennifer J. Siegel, Anesh Prasai, Matthew S. Goldberg, Aaron S. Farberg, Christie Regula, Anna Bar, Julia Kasprzak, David G. Brodland, Shlomo A. Koyfman & Sarah T. Arron. (2024) Integrating the 40-Gene Expression Profile (40-GEP) Test Improves Metastatic Risk-Stratification Within Clinically Relevant Subgroups of High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients. Dermatology and Therapy 14:3, pages 593-612.
Crossref
Crossref
Amit Mittal & Bharat B. Mittal. (2024) Comparative Analysis of US Guidelines for the Management of Cutaneous Squamous Cell and Basal Cell Carcinoma. Journal of Skin Cancer 2024, pages 1-12.
Crossref
Crossref
Jessica Y. Tong, Shyamala C. Huilgol, Craig James & Dinesh Selva. (2023) Recommendations for risk stratification of periocular squamous cell carcinoma. Survey of Ophthalmology 68:5, pages 964-976.
Crossref
Crossref
Shazli Razi, Samavia Khan, Thu M. Truong, Shamail Zia, Farozaan Feroz Khan, Khalid Mahmood Uddin & Babar K. Rao. (2023) Cutaneous Squamous Cell Carcinoma: An Up-to-Date Comprehensive Review with a Focus on Contemporary Optical Imaging Diagnostic Modalities. Dermato 3:2, pages 161-181.
Crossref
Crossref
Razan Masarwy, Shahaf Shilo, Narin Nard Carmel Neiderman, Liyona Kampel, Gilad Horowitz, Nidal Muhanna & Jobran Mansour. (2023) The Prognostic Value and Clinical Utility of the 40-Gene Expression Profile (40-GEP) Test in Cutaneous Squamous Cell Carcinoma: Systematic Review and Meta-Analysis. Cancers 15:9, pages 2456.
Crossref
Crossref
Bo M. Kitrell, Elliot D. Blue, Alfredo SillerJr.Jr., Marissa B. Lobl, Tyler D. Evans, Melodi Javid Whitley & Ashley Wysong. (2023) Gene Expression Profiles in Cutaneous Oncology. Dermatologic Clinics 41:1, pages 89-99.
Crossref
Crossref
A. R. Gevorkov, A. V. Boyko, A. P. Polyakov, A. V. Chernichenko, V. A. Gerasimov, I. A. Meshcheryakova & A. D. Kaprin. (2022) Radiotherapy for cutaneous squamous cell carcinoma: current standards and outlooks. Head and Neck Tumors (HNT) 12:3, pages 53-70.
Crossref
Crossref
Philip R. Cohen & Razelle Kurzrock. (2022) Dermatologic Disease-Directed Targeted Therapy (D3T2): The Application of Biomarker-Based Precision Medicine for the Personalized Treatment of Skin Conditions—Precision Dermatology. Dermatology and Therapy.
Crossref
Crossref
Carrick Burns, Shelby Kubicki, Quoc-Bao Nguyen, Nader Aboul-Fettouh, Kelly M. Wilmas, Olivia M. Chen, Hung Quoc Doan, Sirunya Silapunt & Michael R. Migden. (2022) Advances in Cutaneous Squamous Cell Carcinoma Management. Cancers 14:15, pages 3653.
Crossref
Crossref
Sarah T. Arron, Ashley Wysong, Mary A. Hall, Christine N. Bailey, Kyle R. Covington, Sarah J. Kurley, Matthew S. Goldberg, Julia M. Kasprzak, Ally‐Khan Somani, Sherrif F. Ibrahim, David G. Brodland, Nathan J. Cleaver, Ian A. Maher, Yang Xia, Shlomo A. Koyfman & Jason G. Newman. (2022) Gene expression profiling for metastatic risk in head and neck cutaneous squamous cell carcinoma. Laryngoscope Investigative Otolaryngology 7:1, pages 135-144.
Crossref
Crossref
Jason G. Newman, Mary A. Hall, Sarah J. Kurley, Robert W. Cook, Aaron S. Farberg, Jessica L. Geiger & Shlomo A. Koyfman. (2021)
Adjuvant therapy for h
igh‐risk
cutaneous squamous cell carcinoma:
10‐year
review
. Head & Neck 43:9, pages 2822-2843.
Crossref
Crossref
Cynthia Reyes Barron & Bruce R. Smoller. 2021. Practical Oncologic Molecular Pathology. Practical Oncologic Molecular Pathology
189
206
.